U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07485660) titled 'Care Pathway for Patients With Fabry's Disease (Fabry-PATH)' on March 16.
Brief Summary: Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, ...